Insight

  • Health tech insiders on the hidden cost of ‘free’ digital health tools

    Digital health tools promise convenient access to health information and services. But many operate on a business model that depends on harvesting user data. As more and more of us turn to digital health to support our wellbeing, we asked our members: Where's the line between acceptable data use and exploitation when patients get "free" [...]

  • Digital tools transforming weight management in healthcare

    Weight management in the UK is entering a new clinical phase. Digital systems and prescription medications now shape how clinicians assess, monitor, and support patients living with obesity. This shift moves care away from isolated diet plans and toward structured, medically supervised pathways designed for long-term health. Across healthcare settings, technology supports more accurate assessment [...]

  • How advanced imaging in men’s health can drive a paradigm shift in prostate cancer

    By Dr Peter Seidensticker, head of medical affairs radiology, Bayer Prostate cancer continues to be a significant global health challenge, standing as the second most prevalent cancer among men worldwide. As diagnosis and treatment evolve, it is crucial to develop strategies that effectively balance the need for early detection of aggressive, clinically relevant cancers with [...]

  • Biotech’s promise, patience and path to profit

    By Gil Bashe, managing partner, chair Global Health and Purpose, FINN Partners and HTW correspondent As investors return and IPOs loom, biotech leaders navigate the delicate balance between scientific mission and market maturity. The biotechnology sector remains one of the most dynamic frontiers in modern medicine, yet it remains one of its most financially fragile. [...]

  • Building the foundations for an NHS fit for the future

    By Craig Millard, MD (EVP) @ Harris Health Alliance The NHS 10-Year Plan outlined a bold vision for a more joined-up, digitally enabled, patient-centred, and community-focused health service. Six months on, and the headlines continue to focus on the shiny new, groundbreaking tech and its potential for transformation. That’s all well and good, but that [...]

  • Boosting patient care and security with an SSO/AM solution

    George A. Gellert MD, MPH, MPA, is an epidemiologist focused on using information technology to improve public health outcomes. In this article he discusses the findings from his recent research collaboration with Imprivata, just published in the peer reviewed journal Advances in Health Information Science and Practice (AHISP), the official journal of the American Health [...]

  • OBGYN consultant gives advice for women waiting for specialist care

    More than 750,000 women are currently waiting for hospital gynaecology services, including routine, non-cancer referrals. In England alone, over 580,000 people are waiting for non-cancer gynaecology treatment, with almost half waiting beyond the NHS target of 18 weeks, and more than 18,000 women have been waiting for over a year. “These are not just numbers,” [...]

  • People are more honest with AI than their doctors, new report finds

    People are more likely to open up about their health to artificial intelligence (AI) than to their doctors, according to a new white paper from UK digital health company Aide Health. The report, “Building Patient Trust in AI,” reveals a striking contradiction at the heart of modern healthcare: while most people still feel uneasy about [...]

  • Diagnostics delivery: How Magentus supports the NHS Medium-Term Planning Framework

    The NHS England Medium-Term Planning Framework 2026–2029 sets out a vision for transforming how care is delivered. With targets like treating 92 per cent of patients within 18 weeks, reducing diagnostic waits to under six weeks for 99 per cent of patients, and treating 85 per cent of cancer patients within 62 days, the Framework [...]

  • Breaking into the 50 billion dollar GLP-1 market

    GLP-1 drugs like Ozempic and Mounjaro have transformed weight management around the world, with everyone from celebrities to the NHS touting their benefits for weight loss and type 2 diabetes. Health Tech World speaks to MetaVia CEO Hyung Heon Kim about the history of GLP-1s and the challenge of establishing a new drug in a [...]